Roche Holding AG
RHO
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
markets
Asian markets are globalising
In an era of onshoring and localisation, revenue sources show an increasingly interconnected world economy
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,773.00 | 29.40 | 0.34% |
| CAC 40 | 7,665.91 | 25.64 | -0.33% |
| DAX 40 | 23,909.61 | 123.61 | -0.51% |
| Dow JONES (US) | 44,006.89 | 187.62 | 0.43% |
| FTSE 100 | 8,760.96 | 37.95 | -0.43% |
| HKSE | 24,072.28 | 211.87 | -0.87% |
| NASDAQ | 20,336.18 | 62.72 | 0.31% |
| Nikkei 225 | 40,487.39 | 336.60 | 0.84% |
| NZX 50 Index | 12,602.82 | 19.23 | 0.15% |
| S&P 500 | 6,193.01 | 19.94 | 0.32% |
| S&P/ASX 200 | 8,542.30 | 28.10 | 0.33% |
| SSE Composite Index | 3,444.43 | 20.20 | 0.59% |